1. Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019;Gillessen;Eur Urol,2020
2. Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study;Hansen;Ann Oncol,2018
3. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014
4. KEYNOTE-641: a Phase III study of pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer;Graff;Future Oncol,2021
5. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology;Nuhn;Eur Urol,2019